Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3099 Triple Negative Breast Neoplasms 505 Ovarian Neoplasms 224 Colorectal Neoplasms 189 Carcinoma, Non-Small-Cell Lung 187 Prostatic Neoplasms 180 Neoplasms 172 Lung Neoplasms 164 Neoplasm Metastasis 159 Melanoma 117 Stomach Neoplasms 113 Pancreatic Neoplasms 112 Endometrial Neoplasms 105 Uterine Cervical Neoplasms 93 Squamous Cell Carcinoma of Head and Neck 87 Head and Neck Neoplasms 81 Colonic Neoplasms 81 Carcinoma, Intraductal, Noninfiltrating 80 Sarcoma 63 Breast Carcinoma In Situ 61 Carcinoma, Renal Cell 60 Urinary Bladder Neoplasms 59 Esophageal Neoplasms 58 Motor Activity 57 Brain Neoplasms 50 Lymphedema 42 Breast Cancer Female 40 Advanced Breast Cancer 40 Liver Neoplasms 39 HER2-positive Breast Cancer 38

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Breast × 1 year × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡